Tag: Esperion
Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83r…...
– 30% risk reduction of MACE-4 composite of death from cardiovascular causes, and >25% risk reduction across four key secondary endpoints in primary...
Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the Amer…...
ANN ARBOR, Mich., April 03, 2022 (GLOBE NEWSWIRE) -- Esperion ESPR today presented two new analyses from its clinical development program...